Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE 1 ( January, 2020 ) > List of Articles


Methicillin-resistant Staphylococcus aureus in Intensive Care Unit Setting of India: A Review of Clinical Burden, Patterns of Prevalence, Preventive Measures, and Future Strategies

Ashit Hegde, Varsha Gupta, Jaishid Ahdal, Amit Qamra, Salman Motlekar, Rishi Jain

Keywords : Antibiotic resistance, Hospital-acquired methicillin-resistant Staphylococcus aureus, Intensive care unit, Methicillin-resistant Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus carrier, Methicillin-resistant Staphylococcus aureus colonization, Methicillin-resistant Staphylococcus aureus pipeline, Methicillin-resistant Staphylococcus aureus transmission

Citation Information : Hegde A, Gupta V, Ahdal J, Qamra A, Motlekar S, Jain R. Methicillin-resistant Staphylococcus aureus in Intensive Care Unit Setting of India: A Review of Clinical Burden, Patterns of Prevalence, Preventive Measures, and Future Strategies. Indian J Crit Care Med 2020; 24 (1):55-62.

DOI: 10.5005/jp-journals-10071-23337

License: CC BY-NC 4.0

Published Online: 01-08-2019

Copyright Statement:  Copyright © 2020; The Author(s).


Aim: The aim of this review article is not only to analyze the clinical burden of methicillin-resistant Staphylococcus aureus (MRSA) in intensive care unit (ICU) setting of India, along with the patterns of prevalence and its prevention measures, but also to focus on the new anti-MRSA research molecules which are in late stage of clinical development. Background: Methicillin resistance is reported to be present in 13–47% of Staphylococcus aureus infections in India. Therapeutic options to combat MRSA are becoming less, because of emerging resistance to multiple classes of antibiotics. Intensive care units are the harbinger of multidrug-resistant organisms including MRSA and are responsible for its spread within the hospital. The emergence of MRSA in ICUs is associated with poor clinical outcomes, high morbidity, mortality, and escalating treatment costs. There is an urgency to bolster the antibiotic pipeline targeting MRSA. The research efforts for antibiotic development need to match with the pace of emergence of resistance, and new antibiotics are needed to control the impending threat of untreatable MRSA infections. Review results: Fortunately, several potential antibiotic agents are in the pipeline and the future of MRSA management appears reassuring. Clinical significance: The authors believe that this knowledge may help form the basis for strategic allocation of current healthcare resources and the future needs.

  1. Borg MA, Kraker M, Scicluna EA, van de Sande-Bruinsma N, Tiemersma E, Monen J, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 2007;60(6):1310–1315.
  2. Frinkin SK, Hageman JC, Morrison M, Sanza LT, Sabetti KC, Jernigan JA, et al. Methicillin resistant Staphylococcus aureus in three communities. N Engl J Med 2005;352(14):1436–1444.
  3. World Health Organization. Health care-associated infections fact sheet. Available at:, accessed 17.7.18.
  4. Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006;63(Suppl):S1–S44.
  5. Basak S, Mallick SK, Bose S. Methicillin resistant Staphylococcus aureus (MRSA) infections. J Clin Diagn Res 2010;4:2111–2115.
  6. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39(10):3727–3732.
  7. Geneva: 1996. World Health Organization. The world health report.
  8. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005;365(9466):1256–1258.
  9. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1993;259(5092):227–230.
  10. Musser JM, Kapur V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol 1992;30(8):2058–2063.
  11. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002;99(11):7687–7692.
  12. Indian Network for Surveillance of Antimicrobial Resistance (INSAR) group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern. Indian J Med Res 2013;137(2):363–369.
  13. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India 2010;58(Suppl):32–36.
  14. Jindal N, Malhotra R, Grover P, Singh S, Bansal R, Kaur S. Methicillin resistant Staphylococcus aureus (MRSA) in Malwa region of Punjab (North-West India). Indian J Med Res 2016;143(3):371–372. DOI: 10.4103/0971-5916.182630.
  15. Eshwara VK, Munim F, Tellapragada C, Kamath A, Varma M, Lewis LE, et al. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene. Int J Infect Dis 2013;17(11):e1051–e1055.
  16. Gopalakrishnan R, Sureshkumar D. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physicians India 2010;58(Suppl):25–31.
  17. Datta P, Vasdeva HR, Chander J. Optimization of multiple muco-cutaneous site sampling method for screening MRSA colonization in ICU. Indian J Crit Care Med 2013;17(4):243–245. DOI: 10.4103/0972-5229.118421.
  18. Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: a multicentre study. Indian J Med Microbiol 2006;24(1):34–38.
  19. Mehta AA, Rodrigues CC, Kumar RR, Rattan AA, Sridhar HH, Mattoo VV, et al. A pilot programme of MRSA surveillance in India (MRSA Surveillance Study Group). J Postgrad Med 1996;42(1):1–3.
  20. Tsering DC, Pal R, Kar S. Methicillin-resistant Staphylococcus aureus: prevalence and current susceptibility pattern in Sikkim. J Glob Infect Dis 2011;3(1):9–13. DOI: 10.4103/0974-777X.77289.
  21. Tiwari S, Sahu M, Rautaraya B, Karuna T, Mishra SR, Bhattacharya S. Prevalence of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in a tertiary care hospital. J Indian Med Assoc 2011;109(11):800–801.
  22. Khan N, Khare V, Farid R, Yaqoob S. Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus isolated from different clinical samples. Int J Adv Res 2017;5(3):2195–2201. DOI: 10.21474/IJAR01/3740.
  23. Arora S, Devi P, Arora U, Devi B. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a Tertiary Care Hospital in Northern India. J Lab Physicians 2010;2(2):78–81. DOI: 10.4103/0974-2727.72154.
  24. Pai V, Rao VI, Rao SP. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus [MRSA] isolates at a Tertiary Care Hospital in Mangaluru, South India. J Lab Physicians 2010;2(2):82–84. DOI: 10.4103/0974-2727.72155.
  25. Kaur DC, Chate SS. Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic. J Glob Infect Dis 2015;7(2):78–84. DOI: 10.4103/0974-777X.157245.
  26. Abbas A, Nirwan PS, Srivastava P. Prevalence and antibiogram of hospital acquired-methicillin resistant Staphylococcus aureus and community acquired-methicillin resistant Staphylococcus aureus at a tertiary care hospital National Institute of Medical Sciences. Community Acquir Infect 2015;2(1):13–15. DOI: 10.4103/2225-6482.153857.
  27. Kei J, Richards JR. The prevalence of methicillin-resistant Staphylococcus aureus on inanimate objects in an urban emergency department. J Emerg Med 2011;41(2):124–127.
  28. Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev 2014;27(4):665–690. DOI: 10.1128/CMR.00020-14.
  29. Koessler T, Pasricha J, Camus V, Renzi G, Harbarth S, Schrenzel J, et al. Prevalence and acquisition rate of methicillin resistant Staphylococcus aureus (MRSA) in internal medicine wards at the University Hospital of Geneva (HUG). BMC Proc 2011;5(Suppl 6):P7. DOI: 10.1186/1753-6561-5-S6-P7.
  30. Singh S, Malhotra R, Grover P, Bansal R, Galhotra S, Kaur R, et al. Antimicrobial resistance profile of Methicillin-resistant Staphylococcus aureus colonizing the anterior nares of health-care workers and outpatients attending the remotely located tertiary care hospital of North India. J Lab Physicians 2017;9(4):317–321. DOI: 10.4103/JLP.JLP_8_17.
  31. Kalyani K, Jayakumari K, Kumar JS. Prevalence of MRSA among HCWs of Shri Satya Sai Medical College and Hospital – A tertiary care centre. IOSR J Dent Med Sci 2012;3(2):23–27. DOI: 10.9790/0853-0322327.
  32. Rongpharpi SR, Hazarika NK, Kalita H. The prevalence of nasal carriage of Staphylococcus aureus among healthcare workers at a tertiary care hospital in Assam with special reference to MRSA. J Clin Diagn Res 2013;7(2):257–260. DOI: 10.7860/JCDR/2013/4320.2741.
  33. Mathanraj S, Sujatha S, Sivasangeetha K, Parija SC. Screening for methicillin-resistant Staphylococcus aureus carriers among patients and health care workers of a tertiary care hospital in south India. Indian J Med Microbiol 2009;27:62–64.
  34. Vinodhkumaradithyaa A, Uma A, Srinivasan M, Ananthalakshmi I, Nallasivam P, Thirumalaikolundusubramanian P. Nasal carriage of Methicillin resistant Staphylococcus aureus 2009;62:228–289.
  35. Shobha KL, Rao PS, Thomas J. Survey of Staphylococcus isolates among hospital personnel, environment and their antibiogram with special emphasis on methicillin resistance. Indian J Med Microbiol 2005;23(3):186–188.
  36. Radhakrishna M, D’Souza M, Kotigadde S, Saralaya KV, Kotian MS. Prevalence of methicillin resistant Staphylococcus aureus carriage amongst health care workers of critical care units in Kasturba Medical College Hospital, Mangaluru, India. J Clin Diagn Res 2013;7(12):2697–2700. DOI: 10.7860/JCDR/2013/5160.3735.
  37. Callejo-Torre F, Eiros Bouza JM, Olaechea Astigarraga P, Coma Del Corral MJ, Palomar Martínez M, Alvarez-Lerma F, et al. Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU admission. Infez Med 2016;24(3):201–209.
  38. Catry B, Latour K, Jans B, Vandendriessche S, Preal R, Mertens K, et al. Risk factors for methicillin resistant Staphylococcus aureus: a multi-laboratory study. PLoS One 2014;9(2):e89579.
  39. Kali A, Stephen S, Umadevi S, Kumar S, Joseph NM, Srirangaraj S. Changing trends in resistance pattern of methicillin resistant Staphylococcus aureus. J Clin Diagn Res 2013;7(9):1979–1982. DOI: 10.7860/JCDR/2013/6142.3377.
  40. Saikia L, Nath R, Choudhury B, Sarkar M. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus in Assam. Indian J Crit Care Med 2009;13(3):156–158. DOI: 10.4103/0972-5229.58542.
  41. Lee AS, Lencastre HD, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 2018;4:18033.
  42. Thool VU, Bhoosreddy GL, Wadher BJ. Detection of resistance to linezolid in Staphylococcus aureus infecting orthopedic patients. Indian J Pathol Microbiol 2012;55(3):361–364.
  43. Praharaj I, Sujatha S, Parija SSC. Phenotypic & genotypic characterization of vancomycin resistant Enterococcus isolates from clinical specimens. Indian J Med Res 2013;134(4):549–556.
  44., accessed 20.6.18.
  45. D’Souza N, Rodrigues C, Mehta A. Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. J Clin Microbiol 2010;48(5):1806–1811.
  46. Havey TC, Fowler RA, Pinto R, Elligsen M, Daneman N. Duration of antibiotic therapy for critically ill patients with bloodstream infections: a retrospective cohort study. Can J Infect Dis Med Microbiol 2013;24(3):129–137.
  47. Lubin AS, Snydman DR, Ruthazer R, Bide P, Golan Y. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections. Clin Infect Dis 2011;52(8):997–1002. DOI: 10.1093/cid/cir118.
  48., accessed 19.6.18.
  49., accessed 20.6.18.
  50., accessed 20.6 18.
  51., accessed 20.6.18.
  52., accessed 20.6.18.
  53., accessed 20.6.18.
  54., accessed 20.6.18.
  55., accessed 18.7.18.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.